---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Sep 4, 2008 at 7:39 AM
Subject: Health-related quality of life in patients treated for enterocutaneous fistula.
To: mesothelioma77@gmail.com
[1]Br J Surg. 2008 Sep 2; 95(10): 1280-1286
Visschers RG, Damink SW, van Bekkum M, Winkens B, Soeters PB, van Gemert WG
BACKGROUND:: Patients with enterocutaneous fistulas undergo long intensive treatment. The aim of this study was to investigate the long-term health-related quality of life (HRQL) of these patients. METHODS:: Consecutive patients treated for enterocutaneous fistula between 1990 and 2005 were eligible for this retrospective study. The Karnofsky Performance Scale (KPS), Short Form 36 (SF-36((R))) and the Inflammatory Bowel Disease Questionnaire were used to measure HRQL. The SF-36((R)) was matched with results from healthy controls. Patients also gave information on concurrent medical illnesses. RESULTS:: Of 135 patients, 44 died, 14 were lost to follow-up and 12 refused to participate; of the remaining 65, 62 participated (response rate 81 per cent). HRQL was independent of patient characteristics during treatment. Scores for SF-36((R)) domains were lower than in their matched controls (P
___
Source: http://www.hubmed.org/display.cgi?uids=18763244
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc
http://www.searchinfosource.com/
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Sep 4, 2008 at 7:39 AM
Subject: Health-related quality of life in patients treated for enterocutaneous fistula.
To: mesothelioma77@gmail.com
[1]Br J Surg. 2008 Sep 2; 95(10): 1280-1286
Visschers RG, Damink SW, van Bekkum M, Winkens B, Soeters PB, van Gemert WG
BACKGROUND:: Patients with enterocutaneous fistulas undergo long intensive treatment. The aim of this study was to investigate the long-term health-related quality of life (HRQL) of these patients. METHODS:: Consecutive patients treated for enterocutaneous fistula between 1990 and 2005 were eligible for this retrospective study. The Karnofsky Performance Scale (KPS), Short Form 36 (SF-36((R))) and the Inflammatory Bowel Disease Questionnaire were used to measure HRQL. The SF-36((R)) was matched with results from healthy controls. Patients also gave information on concurrent medical illnesses. RESULTS:: Of 135 patients, 44 died, 14 were lost to follow-up and 12 refused to participate; of the remaining 65, 62 participated (response rate 81 per cent). HRQL was independent of patient characteristics during treatment. Scores for SF-36((R)) domains were lower than in their matched controls (P
___
Source: http://www.hubmed.org/display.cgi?uids=18763244
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc
http://www.searchinfosource.com/